Clinical Trial

REALITY MONITORING AND DOPAMINE

Study acronym: MORDOR
Recruiting
View on ClinicalTrials.gov →
Summary
Reality-monitoring characterizes the ability to determine whether information was perceived in the environment or only imagined . Impaired reality-monitoring abilities have been associated with hallucinations in patients with schizophrenia and patients with Parkinson's disease. The investigators hypothesize a link between dopaminergic (DA) transmission and reality-monitoring.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-02-01; most recent amendment 2026-06-10.
Status change: Not Yet Recruiting → Recruiting 2024-02-13
Trial Details
NCT Number NCT05711082
Lead Sponsor Hôpital le Vinatier
Conditions Neurosciences
Enrollment 39 participants
Start Date 2024-01-15
Primary Completion 2027-01-15 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-06-12